Description
Ipamorelin represents a highly selective synthetic pentapeptide growth hormone secretagogue developed through systematic peptide engineering to optimize growth hormone releasing activity. The compound exhibits the molecular formula C38H49N9O5 with a molecular weight of 711.85 g/mol and is catalogued under CAS number 170851-70-4. The peptide sequence consists of five amino acids arranged as Aib-His-D-2-Nal-D-Phe-Lys-NH2, where Aib represents α-aminoisobutyric acid and D-2-Nal represents D-2-naphthylalanine. The structural design incorporates specific modifications to enhance selectivity and potency for growth hormone secretagogue receptor 1a (GHS-R1a). Originally developed by Novo Nordisk, Ipamorelin has been extensively characterized in laboratory systems and demonstrates consistent growth hormone releasing potency and efficacy in research models. For research use only.
Reviews
There are no reviews yet.